US

Sharon Hamm

This inventor holds 0 USPTO granted patents, plus 2 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sharon Hamm. Retrieved from https://idiyas.com/inventor/sharon-hamm-p8uhb6qd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

 

Average Co-Inventor Count = 1.0


Loading Chart...

Title: The Innovations of Sharon Hamm

Introduction

Sharon Hamm is an accomplished inventor based in the United States. She has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release compositions. Her work focuses on improving the delivery of medications for various cardiovascular conditions.

Latest Patents

Sharon Hamm holds a patent for a controlled release composition comprising a combination of isosorbide dinitrate and hydralazine hydrochloride. This invention is designed to deliver the drug in a pulsed or multi-modal manner, which is beneficial for treating angina, ischemic heart disease, arterial hypertension, and related conditions. The composition allows for the release of the active ingredients in an erodable, diffusion, and/or osmotic-controlled release profile.

Career Highlights

Throughout her career, Sharon has worked with notable companies in the pharmaceutical industry. She has been associated with Elan Pharma International Limited and Alkermes Pharma Ireland Limited. Her experience in these organizations has contributed to her expertise in drug formulation and delivery systems.

Collaborations

Sharon has collaborated with various professionals in her field, including her coworker Gurvinder Rekhi. Their joint efforts have further advanced the development of innovative pharmaceutical solutions.

Conclusion

Sharon Hamm's contributions to controlled release compositions highlight her dedication to improving patient care through innovative drug delivery methods. Her work continues to influence the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…